Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer

This publication has 29 references indexed in Scilit:

• Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication
  The Korean Journal of Pathology, 2012
• Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
  Clinical Cancer Research, 2009
• Cortactin in tumor invasiveness
  Cancer Letters, 2008
• Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1
  Biochemical Journal, 2007
• Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase
  Science, 2004
• Amplification and Overexpression of the EMS 1 Oncogene, a Possible Prognostic Marker, in Human Hepatocellular Carcinoma
  The Journal of Molecular Diagnostics, 2003
• Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence
  The EMBO Journal, 2002
• hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
  Cell, 2001
• Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
  Cell, 2001
• EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival
  Oncogene, 1998